Baird Medical Investment Holdings Limited
Baird Medical Investment Holdings Limited, together with its subsidiaries develops and sells microwave ablation medical devices for minimally invasive tumor treatment in China. The company's medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Baird Medical Investment Holdings Limited was founded in 2012 and is headquartered in Guangzhou, China.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2025 Q4 | -0.55 | $15M | $2M |
| 2025 Q2 | -0.43 | $8M | -$3M |
| 2024 Q4 | 0.38 | $24M | -$5M |
| 2024 Q2 | -0.32 | $13M | -$4M |
| 2023 Q4 | 0.38 | $20M | -$3M |
| 2023 Q2 | 0.08 | $12M | -$621,466 |